Serum CCL21 as a Potential Biomarker for Cognitive Impairment in Spinal Cord Injury.
Yuanzhen ChenLiangke LiangShengnan CaoGuangjian HouQian ZhangHong MaBin Shi
Published in: BioMed research international (2020)
MoCA score has a linear relationship with serum CCL21 quartile, and SCI cognitive function has a negative correlation with serum CCL21. Serum CCL21 is an independent risk factor for cognitive impairment after SCI.